|
|
Application of perioperative iodine-free administration in patients with hyperthyroidism |
XU Zhi-hui HU Huan |
Department of Gastroenterology,CITIC Huizhou Hospital,Guangdong Province,Huizhou 516006,China |
|
|
Abstract Objective To explore the application effect of perioperative iodine-free administration in patients with hyperthyroidism.Methods A total of 78 patients with hyperthyroidism who were treated in our hospital from October 2014 to December 2017 were selected as the research subjects.They were divided into the control group(n=39)and the observation group(n=39)according to the random number table method.In the control group,oral administration of iodine during perioperative period was used,and in the observation group,perioperative iodine-free was adopted.The related surgical indicators,serum free triiodothyronine(FT3)and serum free thyroxine(FT4)levels before and after treatment,incidence of complications after treatment was compared between the two groups.Results There were no significant differences in intraoperative blood loss or operation time between the two groups(P>0.05).The hospital stay in the observation group after treatment was shorter than that in the control group,and the difference was statistically significant(P<0.05).There were no significant differences in FT3 or FT4 level between the two groups after treatment(P>0.05).After treatment,the symptoms of hoarseness,temporary parathyroid injury,and hypothyroidism in the observation group were lower than those in the control group,and the differences were statistically significant(P<0.05).There were no significant differences in the levels of thyroid peroxidase antibody(TPOAb)or thyroglobulin antibody(TGAb)before treatment in the two groups(P>0.05).After treatment,the TPOAb and TGAb indicators in the observation group were lower than those in the control group,and the differences were statistically significant(P<0.05).Conclusion Perioperative iodine-free administration in patients with hyperthyroidism is feasible,and its routine indicators have not changed significantly,and complications have been reduced,which is worthy of promotion and application.
|
|
|
|
|
[10] |
冯晓东,周丽娟,尚宏,等.维持性血液透析患者继发性甲状旁腺功能亢进的围术期护理[J].实用临床医药杂志,2017,21(2):57-59.
|
[1] |
王少强,魏松洋,郑庆杰,等.术前抗甲亢治疗对心脏病合并甲亢患者心内直视术后并发症及血流动力学的影响[J].山东医药,2017,57(5):81-83.
|
[2] |
陈庆法,徐燕,薛方喜,等.年龄因素对行内镜黏膜下剥离术治疗早期单一病灶胃癌患者围手术期临床指标和肿瘤切除效果及并发症的影响[J].中国内镜杂志,2017,23(2):53-57.
|
[3] |
史惠静,宁慧杰,袁红斌.达克罗宁胶浆对甲状腺气管内插管全麻手术患者围手术期安全性及舒适度的影响[J].广东医学,2018,39(10):134-138.
|
[4] |
程相稳,张广德,魏子孝.含碘中药在甲状腺功能亢进症中的应用评述[J].中华中医药杂志,2017,11(9):39-42.
|
[5] |
Felicetti F,Nervo A,Piovesan A,et al.Tyrosine kinase inhibitors rechallenge in solid tumors:a review of literature and a case description with lenvatinib in thyroid cancer[J].Expert Rev Anticancer Ther,2017,17(12):1093-1098.
|
[6] |
景良洪,陈琼科,宋凤萍,等.甲巯咪唑联合穴位敷贴治疗贴对甲状腺功能亢进症患者激素水平及骨代谢指标的影响[J].中国药房,2017,28(21):2905-2908.
|
[7] |
任凤华,李殿玲,卢翠莲,等.综合护理对胸部乳晕入路腔镜下甲状腺切除围术期患者HAMA、HAMD 评分及并发症发生率的影响分析[J].中国地方病防治杂志,2018,11(2):173-174.
|
[8] |
Rossetto JD,Suwannaraj S,Cavuoto KM,et al.Evaluation of postoperative povidone-iodine in adjustable suture strabismus surgery to reduce suture colonization:a randomized clinical trial[J].JAMA Ophthalmol,2016,134(10):1151-1155.
|
[9] |
付言涛,孙辉.甲状腺功能亢进病人围手术期碘准备临床进展[J].中国实用外科杂志,2018,38(6):47-51.
|
[13] |
吴力翔,刘娜.养心氏片在131 碘治疗甲状腺功能亢进症中的疗效研究[J].世界中医药,2017,12(5):1042-1043.
|
[14] |
张建阳,席永昌,冉程,等.不同甲状腺6/24 h 摄碘比值Graves 病患者131 碘治疗效果观察[J].山东医药,2017,57(30):43-45.
|
[11] |
姚晓波,张然,金晓毛,等.超声检查甲状腺功能亢进症伴有甲状腺结节患者的临床特点和131 碘治疗效果分析[J].中国临床保健杂志,2017,20(4):404-407.
|
[12] |
王菊梅.(131)I 放射性治疗甲状腺功能亢进症的近期预后分析[J].安徽医药,2017,21(7):1241-1244.
|
[15] |
王燕,詹先琴,瓦热斯江吾·休尔,等.甲状腺功能亢进患者碘营养状态和维生素D 水平评估[J].中华临床营养杂志,2017,25(5):302-305.
|
|
|
|